| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.36 | 0.04 |